Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY

Yusof, MYM, Vital, EM orcid.org/0000-0003-1637-4755, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2020) Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY. Arthritis & Rheumatology, 72 (7). pp. 1231-1233. ISSN 2326-5191

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: This article is protected by copyright. All rights reserved. This is the peer reviewed version of the following article: Yusof, MYM, Vital, EM, Emery, P et al. (1 more author) (2020) Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY. Arthritis & Rheumatology. ISSN 2326-5191, which has been published in final form at https://doi.org/10.1002/art.41244. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Keywords: B‐cells; Immunoglobulin; Infection; Rheumatoid arthritis; Rituximab; Systemic lupus erythematosus
Dates:
  • Accepted: 25 February 2020
  • Published (online): 5 March 2020
  • Published: July 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Mar 2020 11:17
Last Modified: 27 Oct 2022 03:07
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/art.41244

Export

Statistics